Letter to the editor
Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies – opportunities and open questions. Response

Esteban Martín-Álvareza b José María Larrañaga-Moreiraa bMaría Generosa Crepo-Leiroa b cRoberto Barriales-Villaa b c

For the purchase of this article it is necessary to fill in the following form:

Name *

First name *

Last name *

Email *

Adress *

Number *

City *

Country *

Provincia *

Postal code *

Phone *

N.I.F. *

I wish to receive information about Elsevier products and special promotions by email

I wish to receive information about Elsevier partners' products and special promotions by email

Acepto la Privacy Policy y los Terms and conditions

Customer service

932 415 960

+34 932 415 960

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm.